Business Description
Englewood Lab Inc
NAICS : 322291
SIC : 2676
ISIN : KR8840110108
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.37 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | 0.39 | |||||
Interest Coverage | 41.41 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 5.87 | |||||
Beneish M-Score | -1.49 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.2 | |||||
3-Year EBITDA Growth Rate | 49.7 | |||||
3-Year EPS without NRI Growth Rate | 74.3 | |||||
3-Year FCF Growth Rate | 76.7 | |||||
3-Year Book Growth Rate | 23.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.14 | |||||
9-Day RSI | 69.11 | |||||
14-Day RSI | 66.7 | |||||
6-1 Month Momentum % | -1.31 | |||||
12-1 Month Momentum % | 100.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.56 | |||||
Quick Ratio | 1.74 | |||||
Cash Ratio | 0.35 | |||||
Days Inventory | 95.62 | |||||
Days Sales Outstanding | 88.32 | |||||
Days Payable | 33.56 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.62 | |||||
Dividend Payout Ratio | 0.1 | |||||
Forward Dividend Yield % | 0.62 | |||||
5-Year Yield-on-Cost % | 0.62 | |||||
Shareholder Yield % | 5.12 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 23.13 | |||||
Operating Margin % | 13.96 | |||||
Net Margin % | 10.03 | |||||
FCF Margin % | 8.77 | |||||
ROE % | 19.51 | |||||
ROA % | 13.79 | |||||
ROIC % | 18.61 | |||||
ROC (Joel Greenblatt) % | 28.25 | |||||
ROCE % | 26.08 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.37 | |||||
PE Ratio without NRI | 15.55 | |||||
Price-to-Owner-Earnings | 16.35 | |||||
PS Ratio | 1.54 | |||||
PB Ratio | 2.76 | |||||
Price-to-Tangible-Book | 2.76 | |||||
Price-to-Free-Cash-Flow | 17.84 | |||||
Price-to-Operating-Cash-Flow | 15.55 | |||||
EV-to-EBIT | 10.63 | |||||
EV-to-EBITDA | 9.24 | |||||
EV-to-Revenue | 1.51 | |||||
EV-to-FCF | 17.32 | |||||
Price-to-Projected-FCF | 3.42 | |||||
Price-to-Graham-Number | 1.38 | |||||
Price-to-Net-Current-Asset-Value | 4.34 | |||||
Earnings Yield (Greenblatt) % | 9.4 | |||||
FCF Yield % | 5.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Englewood Lab Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 205,690.822 | ||
EPS (TTM) (â‚©) | 1039 | ||
Beta | 0.68 | ||
Volatility % | 84.38 | ||
14-Day RSI | 66.7 | ||
14-Day ATR (â‚©) | 1026.330268 | ||
20-Day SMA (â‚©) | 14410.5 | ||
12-1 Month Momentum % | 100.89 | ||
52-Week Range (â‚©) | 6930 - 17900 | ||
Shares Outstanding (Mil) | 19.87 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Englewood Lab Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Englewood Lab Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Englewood Lab Inc Frequently Asked Questions
What is Englewood Lab Inc(XKRX:950140)'s stock price today?
When is next earnings date of Englewood Lab Inc(XKRX:950140)?
Does Englewood Lab Inc(XKRX:950140) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |